Kommentar
The Evolving Landscape of Biologics—Biosimilars, Biobetters, and Bioparallels
JAMA Dermatology · 01.04.2025 · 161 (4) · 355
DOI: 10.1001/jamadermatol.2025.0049 ↗Kurz gefasst
Kommentar in der Zeitschrift JAMA Dermatology, erschienen am 01.04.2025. Verfasst von Ivo Abraham und 1 weiteren Autor:innen. Beteiligte Einrichtung: Matrix45, LLC, Tucson, Arizona. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 16 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Autor:innen und Institutionen
- Matrix45, LLC, Tucson, Arizona.
- Department of Pharmacy, Practice, and Science and Center for Health Outcomes and Pharmacoeconomic Research, R. Ken Coit College of Pharmacy, University of Arizona, Tucson.
- Associate Editor for Quantitative Methods, JAMA Dermatology.
Zitieren
APA
Abraham, I., & MacDonald, K. (2025). The Evolving Landscape of Biologics—Biosimilars, Biobetters, and Bioparallels. JAMA Dermatology, 161(4), 355. https://doi.org/10.1001/jamadermatol.2025.0049
Vancouver
Abraham I, MacDonald K. The Evolving Landscape of Biologics—Biosimilars, Biobetters, and Bioparallels. JAMA Dermatology. 2025;161(4):355. doi:10.1001/jamadermatol.2025.0049
BibTeX
@article{Abraham2025,
author = {Abraham, Ivo and MacDonald, Karen},
title = {The Evolving Landscape of Biologics—Biosimilars, Biobetters, and Bioparallels},
journal = {JAMA Dermatology},
year = {2025},
volume = {161},
number = {4},
pages = {355},
doi = {10.1001/jamadermatol.2025.0049}
}
EUVIMED